Post
of 224,629
$SNGX News Article - Soligenix Achieves Significant Enrollment Milestone for its Pivotal Phase 3 Clinical Trial of SGX942 in the Treatment of Oral Mucositis in Head and Neck Cancer https://marketwirenews.com/news-releases/soli...21938.html
My Twitter: WhyteStocks